If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
In the mountainous region of Nagaland in North East India, MSF is working alongside the local and national authorities to provide treatment for patients with drug resistant TB in the town of Mon.